Quantbot Technologies’s Enfusion, Inc. ENFN Stock Holding History

Quantbot Technologies’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-98,206	Closed	-$1.09M	–	2017
2025 Q1	$1.09M	Buy	98,206 +84,256	+604%	+$931K	0.03%	648
2024 Q4	$144K	Buy	+13,950	New	+$135K	0.01%	1120
2024 Q2	–	Sell	-11,521	Closed	-$107K	–	1990
2024 Q1	$107K	Buy	+11,521	New	+$101K	0.01%	1156
2023 Q2	–	Sell	-7,201	Closed	-$75.6K	–	2042
2023 Q1	$75.6K	Buy	7,201 +6,213	+629%	+$68.5K	0.01%	1161
2022 Q4	$9.55K	Buy	+988	New	+$11.1K	﹤0.01%	1513
2022 Q3	–	Sell	-17	Closed	–	–	2187
2022 Q2	$0	Sell	17 -10,298	-100%	-$114K	﹤0.01%	2215
2022 Q1	$131K	Buy	+10,315	New	+$158K	0.01%	969

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quantbot Technologies's ENFN Position: Q2 2025 in Review

Quantbot Technologies sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 98,206 shares — an estimated $1.09M sold.

Quantbot Technologies first reported a position in ENFN in Q1 2022 and held it in 7 quarters. The position peaked at $1.09M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Quantbot Technologies reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Quantbot Technologies sold 98,206 Enfusion, Inc. shares in Q2 2025, an estimated $1.09M.
Quantbot Technologies first reported a position in Enfusion, Inc. in Q1 2022 and held it in 7 quarters.
Quantbot Technologies's Enfusion, Inc. position peaked at $1.09M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Quantbot Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.